Showing results (111-120 of 137) with videos related to
Sort By:
Pageof 14
Gut and Liver|April 1, 2025
Endoscopic Features of Gastrointestinal Amyloidosis: A Proposed Endoscopic ClassificationJoo Hye Song, Hye Mi Jung, Ji Won Kim, et al.Cancer Research and Treatment|July 3, 2025
A Phase II Study of Daratumumab in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma Who Received One Prior Line of Therapy (KMM1906)Kwai Han Yoo, Sang Eun Yoon, Ka-Won Kang, et al.Blood Cancer Journal|November 20, 2022
Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working PartySung-Hoon Jung, Kihyun Kim, Sang Eun Yoon, et al.Scientific Reports|July 17, 2020
Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab eraGa-Young Song, Sang Eun Yoon, Seok Jin Kim, et al.Journal of Hepatology|August 19, 2020
Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinomaChang Gon Kim, Chan Kim, Sang Eun Yoon, et al.Cancer Research and Treatment|November 10, 2023
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in KoreaJi Yun Lee, Ji Hyun Kwon, Joon Young Hur, et al.Blood Advances|December 9, 2025
Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B cell lymphomaSang Eun Yoon, Woorim Kang, Junhun Cho, et al.Blood|August 9, 2020
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 studySeok Jin Kim, Jing Quan Lim, Yurike Laurensia, et al.Cancer Research and Treatment|April 5, 2022
A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma:Incorporation of Serum β-2 Microglobulin to PINKSora Kang, Hyungwoo Cho, Shin Kim, et al.Cancer Research and Treatment|June 2, 2026
Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910)Jun Ho Yi, Sang Eun Yoon, Ji Hyun Lee, et al.Pageof 14